The Legacy That Moves at a Mite's Pace

Koppert Biological Systems has spent 59 years turning bags of live predatory mites and bumblebees into a 417 million euro business, precisely because its production line, biology itself, cannot be accelerated for any price.

Most executives treat production capacity as a dial to turn: hire another shift, lease another factory, borrow against tomorrow's revenue to grow today.

This approach creates a business that can only move as fast as its balance sheet allows, mistaking debt capacity for operational capability and forgetting that some products refuse to be rushed at any price.

Building legacy through biological constraint requires an inverted discipline: designing an entire company around a clock it does not control.

Koppert built around exactly that constraint, rearing predatory mites and bumblebees whose reproduction sets the delivery schedule and turning what looks like an operational weakness into a €417M moat no chemical competitor can simply spend its way around.

Case Study: How Koppert Grew a 417 Million Euro Moat Through Refusing to Rush Biology

In 1967, a Dutch cucumber grower named Jan Koppert faced a problem no amount of chemical spraying could fix: the pesticides protecting his greenhouse against spider mites had stopped working.

Rather than switch products, Koppert and his son Peter traveled to research stations in the United Kingdom and then Switzerland, searching for a natural predator that could do what chemistry no longer could.

What they found was a mite barely half a millimeter long, and a business model no chemical company could easily copy.

The predator, Phytoseiulus persimilis, hunted spider mites voraciously and reproduced quickly enough to keep pace with its prey, completing its life cycle from egg to adult in as few as five days in warm conditions and up to 25 days in cooler ones, a timetable no factory schedule could compress.

Koppert did not simply use the mite in his own greenhouse.

He decided to breed and sell it to fellow growers, founding a company built entirely around a living product that ate, mated, and multiplied on its own internal clock. His son Paul joined the venture in 1972, and nephew Henri Oosthoek followed in 1977, forming a family enterprise whose core inventory could never be manufactured faster than nature allowed.

Turning a mite into a business required inventing an entirely new kind of supply chain.

Koppert built an in-house research department, opened its first subsidiary in the United Kingdom, and added a second living product, the parasitic wasp Encarsia formosa, to fight whitefly.

By 1987 the company had moved into commercial bumblebee production, and today its decentralized bio-factories span the Netherlands, Slovakia, Spain, Turkey, Mexico, and the United States, each positioned close to growers because a living shipment often has only days to reach its destination before its usefulness begins to decline.

In the late 1960s, handing a grower a bag of live mites instead of a chemical sprayer looked to most of the industry like an act of faith, not commerce. Spider mites were an enemy to be killed outright, not managed through a competing population of predators that needed feeding, humidity, and careful timing to survive shipment.

Koppert's wager was that discipline around a perishable, reproducing product could become more defensible over decades than any patent on a chemical formula.

The scale that discipline eventually produced is substantial. By its fiftieth anniversary in 2017, Koppert had grown into a company with an annual turnover of 190 million euros, 1,200 employees, and subsidiaries in 26 countries, exporting to more than 90 nations in total.

Three years later, turnover had climbed to roughly 300 million euros across offices in 30 countries, still run entirely by the founding family without outside shareholders.

In February 2024, Koppert accepted 140 million euros in preferred share capital from HAL Investments, a Dutch investment company built on proceeds from the 1989 sale of the Holland America Line and controlled by a family that has held it privately for more than a century.

The deal was explicitly framed as preserving Koppert's identity as a family company, not diluting it. By 2025, Koppert's turnover had reached 417 million euros across 2,635 employees in 34 countries, and Dutch regulators had cleared HAL and a co-investor to take joint control of the parent group.

Growth in capital did not mean growth in haste. In May 2025, René Koppert stepped down as chief executive to join the Supervisory Board after 15 years at the company and more than three years running it, the longest-serving member of the family's third generation.

For the first time since 1967, Koppert began searching outside the family for its next chief executive, an acknowledgment that even a business engineered around patience must eventually treat leadership succession as its own kind of biological handoff.

The paradox at the center of Koppert's growth is that its real product was never the mite or the bumblebee.

Any laboratory can theoretically breed a predatory mite or rear a bumblebee colony. Few can replicate the accumulated discipline of shipping a living population that must be correctly aged, correctly timed, and temperature-controlled through customs zones and cold chains before it dies of neglect or old age.

A chemical competitor can scale production by adding equipment, shifts, or manufacturing capacity.

Koppert's factory is a reproductive cycle that runs on its own schedule, and 59 years of refusing to argue with that schedule created a moat no acquisition or amount of patient capital can shortcut.

From Production Schedules to Biological Deadlines

1. Honor the Organism's Deadline

Conventional operations treat maturation time as a cost to engineer away.

Acorn-fed Iberian pigs mature slowly, and Cinco Jotas then cures its hams for years in mountain cellars. Neither clock can simply be shortened because demand rises.

The wait is not a production bottleneck. It is part of what makes the product valuable.

Removing it would remove part of the reason customers pay the premium.

2. Protect the Core While the Package Evolves

Authenticity does not require leaving everything untouched.

Guinness has brewed in Dublin since 1759 while repeatedly changing how its beer reaches the customer, from the nitrogen widget to MicroDraught.

Packaging, technology, and the experience around the product can evolve without sacrificing what customers came for.

Durable brands change around the core without changing the core itself.

3. Locate the Perishable Core Close to the Customer

Distance becomes expensive when the product starts deteriorating the moment it is ready.

Roughly 20 million flowers move through the Aalsmeer operation of Royal FloraHolland each day, with cold-chain logistics built around getting highly perishable inventory from growers toward buyers quickly.

A competitor can add warehouses and trucks. It cannot recover the useful life already lost in transit.

Perishability becomes a geographic advantage when the supply chain is designed around it from the beginning.

4. Build Tomorrow's Capacity Today

Demand can arrive faster than inventory when the production cycle is measured in decades.

Traditional Balsamic Vinegar of Modena cannot earn its PDO designation until it has aged for at least 12 years, with the oldest classification requiring 25. The producers behind the Consorzio therefore have to make capacity decisions years before they know exactly what demand will look like.

You cannot solve a twelve-year production shortage with next year's capital.

More barrels can increase future supply, but they cannot create finished inventory now. When time is part of the production process, capacity planning becomes an exercise in committing before demand makes the decision obvious.

From strategy to legacy

Capital can buy another factory, another shift, another distribution center. It cannot make a mite reproduce faster, a vine mature sooner, or a cured product become ready before its time.

The companies that endure learn where acceleration stops working, then build their strategy around that boundary rather than fighting it. Over decades, that constraint can become the very advantage competitors cannot buy their way around.

What part of your business becomes more valuable precisely because it refuses to move faster?

- Legacy Beyond Profits